Cargando…

Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials

Molecular markers define the diagnosis of glioblastoma in the new WHO classification of 2016, challenging neuro-oncology centers to provide timely treatment initiation. The aim of this study was to determine whether a time delay to treatment initiation was accompanied by signs of early tumor progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Merkel, Andreas, Soeldner, Dorothea, Wendl, Christina, Urkan, Dilek, Kuramatsu, Joji B., Seliger, Corinna, Proescholdt, Martin, Eyupoglu, Ilker Y., Hau, Peter, Uhl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378726/
https://www.ncbi.nlm.nih.gov/pubmed/28101701
http://dx.doi.org/10.1007/s11060-016-2362-z